BK: Don't you consider it possible that the reaction we're seeing is due to the uplisting and (unfounded) fears some have about impact on pps? I could see some people selling if they thought that CTIX was a weak company with a long shot at clinical successes and in financial straits. I've seen that before. But, we are in the exact opposite position of incredible strength, and an uplist to the institutional fishing waters will only benefit us. Yes, there'll be shorts, but, so what? Takes all types to make the market.